Peptides inhibiting vascular endothelial cell migration
CA 2362258 A1 · Owner: Kyowa Hakko Kogyo Co. Ltd. · Inventors: Yamasaki, Motoo; Tsukuda, Eiji; Miyamoto, Kaoru
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Novel peptides inhibiting the migration of vascular endothelial cells which are useful as remedies for diseases in association with abnormal angiogenesis for example, solid tumor, inflammatory diseases such as arthritis and ocular agiogenic diseases such as diabetic retinitis. Peptides having an activity of inhibiting the migration of vascular endothelial cells represented by the following general formula (I) or pharmacologically acceptable salts thereof: R1-A-R2 wherein R1 represents hydrogen optionally substituted alkanoyl, optionally substituted aroyl optionally substituted heteroarylcarbonyl optionally substituted alkoxycarbonyl, optionally substituted aryloxycarbonyl or …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 9, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 9, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 9, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.